Back to School: How biopharma can reboot drug development. Access exclusive analysis here

IPO queue

IPO queue

Company Filed Proposed shares To be raised (A) Price range Shares after Status (B)
Pronova (Oslo) 9/26/07 25M NOK650M ($117.6M) NOK23-NOK29 300.8M Mkt
Elixir Pharma 9/21/07 TBD Up to

Read the full 319 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE